UPDATE: Berenberg Starts Athira Pharma (ATHA) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/25/2024
- S&P 500 ends higher as markets weigh rising yields, upbeat corporate results
- Meta Platforms reports softer Q2 revenue guidance on plans to boost spending on AI
- IBM (IBM) announces mixed Q1 results, HashiCorp acquisition; shares down
- Equities mixed as investors eye earnings; yen on intervention watch
- ServiceNow (NOW) stock falls as refreshed subscription outlook trails estimates
- Meta Platforms (META) Tops Q1 EPS by 39c, Offers Guidance
- Hasbro (HAS) brand strength sees earnings top expectations
- IBM (IBM) announces mixed Q1 results, HashiCorp acquisition; shares down
- Seagate Technology (STX) Enters $600M Asset Purchase Agreement with Avago
- Crude Inventory Declined 6.4 Million Barrels Last Week
- After-hours movers: Meta, Ford, IBM, ServiceNow and more
- Midday movers: Tesla, Boeing rise; Uber, Old Dominion Freight fall
- After-hours movers: Tesla, Texas Instruments, Seagate, Visa and more
- Midday movers: PepsiCo, JetBlue fall; GM, Danaher and UPS rise
- After-hours movers: Cadence Design Systems, Cleveland-Cliffs, Riot Platforms, and more
Athira Pharma Inc. (ATHA) Mails Shareholder Letter Highlighting the Strength of its Board and Record of Deliberate Board Refreshment
April 20, 2022 9:04 AM EDTAthira Pharma, Inc. (NASDAQ: ATHA) today mailed a letter to shareholders highlighting the depth and breadth of experience and expertise on the companys board.
Athira has a thorough, deliberate process to review board composition and over the past year, the company has added three independent... More
Stifel Reiterates Buy Rating, $36 Price Target on Athira Pharma (ATHA) Ahead of ATH-1017 Readout
April 19, 2022 5:10 PM EDTStifel analyst Paul Matteis reiterated a Buy rating and $36.00 price target on Athira Pharma (NASDAQ: ATHA), ahead of the company's ATH-1017 readout.
The analyst comments: "Within our ACT-AD preview, we lay out our hurdle for positive ATH-1017 data as we approach the ph2... More
